Creative Medical Technology Holdings, Inc. announced that it has entered into a securities purchase agreement with several institutional investors for a private placement of 7,555,556 common shares at $2.25 per share for gross proceeds of $17,000,001 on April 29, 2022. The company will also issue unregistered warrants to purchase 15,111,112 common shares exercisable at $2 per share exercisable until five years. The transaction is expected to close on or about May 3, 2022, subject to satisfaction of customary closing conditions.
Creative Medical Technology Holdings, Inc.
Equities
CELZ
US22529Y4089
Biotechnology & Medical Research
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.57 USD | -1.11% | +8.41% | -21.69% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-21.69% | 48.67L | |
+16.68% | 12TCr | |
+20.13% | 12TCr | |
+21.22% | 2.66TCr | |
-23.09% | 1.99TCr | |
-17.47% | 1.63TCr | |
-45.95% | 1.55TCr | |
-18.31% | 1.55TCr | |
+59.46% | 1.48TCr | |
+3.24% | 1.37TCr |
- Stock Market
- Equities
- CELZ Stock
- News Creative Medical Technology Holdings, Inc.
- Creative Medical Technology Holdings, Inc. announced that it expects to receive $17.000001 million in funding